Design and evaluation of 1,7-naphthyridones as novel KDM5 inhibitors.
Labadie SS, Dragovich PS, Cummings RT, Deshmukh G, Gustafson A, Han N, Harmange JC, Kiefer JR, Li Y, Liang J, et al. Bioorg Med Chem Lett. 2016 Sep 15; 26(18):4492-4496. Epub 2016 Jul 29.